Authored by Naveen Athrappully via The Epoch Times,
The U.S. Border Patrol released zero illegal immigrants into the United States from the southern border for the 14th consecutive month in June.
Border enforcement is at “historic levels,” and illegal crossings last month remained significantly low, Customs and Border Protection (CBP) said in a July 16 statement. Border Patrol apprehended 9,848 people at the southwest border last month, 94 percent lower than the monthly average under the previous administration. It was also lower than the number of people “apprehended in 4 days” in June 2024.
“As I have said many times, leadership and policy matter. When laws are enforced, fewer people will break the law. Under the leadership of President [Donald] Trump and [Homeland Security] Secretary [Markwayne] Mullin, CBP is fully enforcing our immigration and border security laws,” CBP Commissioner Rodney S. Scott said in the statement.
“CBP is preventing dangerous criminal aliens and illicit narcotics from entering our communities, enhancing the safety of every American for generations to come.”
Last month, the Border Patrol received a funding boost for its anti-illegal immigration efforts when Trump signed the Secure America Act into law. The legislation provides $70 billion to Immigration and Customs Enforcement (ICE) and Border Patrol through Sept. 30, 2029, beyond Trump’s current term.
The bill allocated $22 billion for Border Patrol to recruit, train, equip, and pay agents and staff members. Out of the $22 billion, about $13 billion was specifically set aside for immigration enforcement operations. The legislation also granted $5 billion to be used for border security technology and screening systems.
After the bill was passed by the House on June 9, House Speaker Mike Johnson (R-La.) justified the legislation, saying Democrats will not be able to defund Border Patrol and ICE for the next few years. House Majority Leader Steve Scalise (R-La.) said the bill supported law enforcement in the country.
Sen. Tammy Duckworth (D-Ill.) and Sen. Dick Durbin (D-Ill.) criticized the funding as a “disastrous bill” to bankroll ICE and Border Patrol, according to a June 12 statement from Duckworth’s office.
“There are an infinite number of ways we could be working to help Illinoisans get by, and it’s despicable that Trump would rather bankroll ICE and Border Patrol’s reign of terror than keep his promise and lower costs for the middle class,” Duckworth said in the statement.
2025–2029 StrategyAs the CBP counters the influx of illegal immigrants into the United States, the agency has reported strong growth in its Border Patrol workforce.
In a June 24 statement, CBP said that 21,471 Border Patrol agents were serving on America’s front lines—the highest employee count in the agency’s 102-year history.
CBP credited investments from the One Big Beautiful Bill Act, signed into law by Trump last year, for fueling “increased applicant interest” and enabling the agency to attract top talent.
CBP said in a July 16 statement that it was filling in mission-critical roles in law enforcement and mission operations support positions at various locations throughout the United States, and it stated that it planned to conduct a virtual event on July 23 to highlight the career opportunities open to military spouses and veterans.
“CBP is an extremely welcoming employer for veterans and military spouses,” CBP Office of Human Resources Management Assistant Commissioner Andrea Bright said in the statement.
According to the 2025–2029 Border Patrol Strategy, the agency aims to counter illegal immigrant influx by expanding physical infrastructure, such as wall barriers, checkpoints, and permanent towers, in all regions of the country.
The agency seeks to deploy advanced autonomous surveillance systems as part of enhancing its detection and identification capabilities. Moreover, Border Patrol plans to proactively forecast high-risk crossing patterns and “strategically position resources to disrupt and deter illicit activities.”
Tyler Durden Tue, 07/21/2026 - 09:20Novo Nordisk wrote in a press release that it is suing GLP-1 rival Eli Lilly in federal court in New Jersey, alleging nationwide "deceptive advertising" for Zepbound and Mounjaro. The company claims Lilly misleads consumers by comparing Lilly's highest doses with lower doses of Novo's Wegovy and Ozempic.
Novo claims Lilly's Zepbound advertising campaign relies on outdated studies that exclude the 7.2-milligram dose of Wegovy, approved in March 2026, which produced an average weight loss of about 19%. Novo also stated that there has been no head-to-head trial comparing the highest approved doses of the two drugs.
"A lawsuit, filed today in federal court, challenges a nationwide pattern of deceptive advertising which confuses consumers by using outdated studies to compare the highest injectable doses of Lilly's medicines against lower doses of Novo Nordisk's injectable medicines for obesity and type 2 diabetes," Novo wrote in the release.
What Novo seeks:
Through this action, Novo Nordisk is seeking a permanent injunction requiring Lilly to pull its misleading comparative advertising across all platforms and to conduct a corrective advertising campaign. We have also communicated to Lilly that if they do not voluntarily pull these ads, Novo Nordisk intends to file a formal motion with the Court in the coming days seeking a preliminary injunction to immediately block them, with evidence that consumers are being confused and misled by Lilly's ads.
The lawsuit comes as Novo and Lilly battle for share of a global GLP-1 market projected to exceed $120 billion by 2030, according to Bloomberg Intelligence. Novo entered the obesity market first with Wegovy, but Lilly has since overtaken its rival with Zepbound and now leads in sales.
The divergence is reflected in their share prices: Novo's stock is flat this year and trading at lows last seen in 2021, while Lilly is at record highs.
Novo is pursuing a turnaround under its new CEO, expanding partnerships with telehealth companies and rolling out a new oral weight-loss drug. Will that be enough to reverse the stock?
Tyler Durden Tue, 07/21/2026 - 09:00